X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB CADILA HEALTHCARE UNICHEM LAB/
CADILA HEALTHCARE
 
P/E (TTM) x -276.1 24.0 - View Chart
P/BV x 2.0 6.0 33.7% View Chart
Dividend Yield % 1.3 0.8 161.2%  

Financials

 UNICHEM LAB   CADILA HEALTHCARE
EQUITY SHARE DATA
    UNICHEM LAB
Mar-17
CADILA HEALTHCARE
Mar-17
UNICHEM LAB/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs320460 69.5%   
Low Rs221305 72.5%   
Sales per share (Unadj.) Rs167.292.1 181.5%  
Earnings per share (Unadj.) Rs12.014.8 80.7%  
Cash flow per share (Unadj.) Rs16.918.5 91.6%  
Dividends per share (Unadj.) Rs3.003.20 93.8%  
Dividend yield (eoy) %1.10.8 132.6%  
Book value per share (Unadj.) Rs117.068.0 172.1%  
Shares outstanding (eoy) m90.881,023.74 8.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.64.2 39.0%   
Avg P/E ratio x22.625.8 87.6%  
P/CF ratio (eoy) x16.020.7 77.2%  
Price / Book Value ratio x2.35.6 41.1%  
Dividend payout %25.121.6 116.2%   
Avg Mkt Cap Rs m24,578391,581 6.3%   
No. of employees `0005.216.9 30.8%   
Total wages/salary Rs m2,48715,002 16.6%   
Avg. sales/employee Rs Th2,928.35,594.5 52.3%   
Avg. wages/employee Rs Th479.4890.1 53.9%   
Avg. net profit/employee Rs Th209.4899.9 23.3%   
INCOME DATA
Net Sales Rs m15,19594,295 16.1%  
Other income Rs m1101,286 8.6%   
Total revenues Rs m15,30595,581 16.0%   
Gross profit Rs m1,78819,036 9.4%  
Depreciation Rs m4523,750 12.0%   
Interest Rs m34450 7.5%   
Profit before tax Rs m1,41316,122 8.8%   
Minority Interest Rs m0338 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3 0.0%   
Tax Rs m3261,289 25.3%   
Profit after tax Rs m1,08715,168 7.2%  
Gross profit margin %11.820.2 58.3%  
Effective tax rate %23.18.0 288.5%   
Net profit margin %7.216.1 44.5%  
BALANCE SHEET DATA
Current assets Rs m6,42660,223 10.7%   
Current liabilities Rs m3,91753,058 7.4%   
Net working cap to sales %16.57.6 217.3%  
Current ratio x1.61.1 144.5%  
Inventory Days Days6870 96.9%  
Debtors Days Days7788 87.3%  
Net fixed assets Rs m7,41072,984 10.2%   
Share capital Rs m1821,024 17.8%   
"Free" reserves Rs m10,45468,576 15.2%   
Net worth Rs m10,63669,600 15.3%   
Long term debt Rs m424,684 0.0%   
Total assets Rs m15,258152,207 10.0%  
Interest coverage x42.936.8 116.5%   
Debt to equity ratio x00.4 0.1%  
Sales to assets ratio x1.00.6 160.8%   
Return on assets %7.310.3 71.6%  
Return on equity %10.221.8 46.9%  
Return on capital %13.617.9 75.8%  
Exports to sales %24.10-   
Imports to sales %4.90-   
Exports (fob) Rs m3,666NA-   
Imports (cif) Rs m752NA-   
Fx inflow Rs m5,29821,280 24.9%   
Fx outflow Rs m010,874 0.0%   
Net fx Rs m5,29810,406 50.9%   
CASH FLOW
From Operations Rs m68313,495 5.1%  
From Investments Rs m-1,316-29,103 4.5%  
From Financial Activity Rs m59223,158 2.6%  
Net Cashflow Rs m-407,556 -0.5%  

Share Holding

Indian Promoters % 50.1 74.8 67.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 8.3 181.9%  
FIIs % 3.0 5.9 50.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 11.0 288.2%  
Shareholders   20,176 44,069 45.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  BIOCON LTD  ALEMBIC LTD  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 50.4%

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, CADILA HEALTHCARE has posted a net profit of Rs 6 bn (up 50.4% YoY). Sales on the other hand came in at Rs 33 bn (up 28.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jun 22, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - ALEMBIC PHARMA COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS